"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.
Clinical trial NCT05888701 · UNKNOWN
Trial details
- NCT number
- NCT05888701
- Sponsor
- University of Milano Bicocca
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-08
- Primary completion
- 2023-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.